Durin Life Sciences, Inc.

Amendment
CIK: 0001797306·Biotechnology·NEW JERSEY·Filed: Mar 18, 2025
Total Offering

$5,499,900

Amount Sold

$5,499,900

Investors

3

First Sale

Mar 16, 2021

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Mert Sahin
Related Person
Robert Nagele
Related Person
Rene Chaze
Related Person

Company

Durin Life Sciences, Inc.

2 MEDICAL CENTER DR #213A

STRATFORD, NJ, 08084

877-387-4657

SEC Filing

0001797306-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Durin Life Sciences, Inc. Form D Filing — $5,499,900 | FilingFlow